Contact
TÜBİTAK Marmara Research Center
Product and Service Sales
For information on our products and services and for your questions, please contact us through the e-mail address below.
İlaç ve Tıbbi Cihaz
Production Of Therapeutical Nanostructures
Production of biocompatible niosomal therapeutic carrier nanostructures
Products:
- Nanostructured vesicular topical niosomal formulations
- Curcumin-loaded niosomal solution
Usage Area:
Pharmaceutical, Biomedical Materials, Cosmetics, Chemistry, Materials
Original High Efficacy Monoclonal Antibodies
Production of monoclonal antibodies against various antigens (human, plant, animal pathogens) for use in diagnostic systems by cell culture techniques in Diagnostic Technologies Laboratory
Capabilities of Genetic Engineering and Biotechnology Institute:
Production Of Precious Metal Catalysts
The first domestic production and recycle of precious metal-based catalysts that used to be imported for the synthesis of pharmaceutical raw materials, and plant installation
Capabilities of The Institute of Chemical Technology:
Hemostatic Tamponade Material
Domestically produced anti-bacterial tamponade material that controls and stops arterial bleeding by accelerating blood clotting
Product Properties:
- Hemostatic structure providing rapid clotting in severe injuries
- Antibacterial
- Biocompatible
- Stop bleeding in 90 seconds
- Competitive cost in comparison to imported substitute products
Usage Area:
Antibodies For Cystic Fibrosis Diagnosis
Immunoreactive Trypsinogen (IRT) and Pancreatitis-Associated Protein (PAP) antibodies for the markers of Cystic Fibrosis disease which was included in Newborn Screening in 2015 and demanded in the amount of 2.500.000 tests per year for diagnosis
Products:
Monoclonal Antibodies For Hepatitis Diagnosis
Production of monoclonal antibodies used in antigen-antibody relationship-based systems (ELISA, strip, etc.) for the diagnosis of hepatitis disease agents
Capabilities of Genetic Engineering and Biotechnology Institute:
- Hepatitis B virus (s antigen) production
- Hepatitis B virus (c antigen) production
- Anti-M13 phage production
- Hepatitis B virus (e antigen) production
Usage Area:
Microbial Products
High efficiency production of microbial products having industrial and biotechnological importance by using microorganisms selected from nature through screening techniques
Capabilities of Genetic Engineering and Biotechnology Institute:
Biotechnological Drug Against Cancer
Development of biotechnological drugs for use in cancer treatment by employing advanced technologies in world standards
Capabilities of Genetic Engineering and Biotechnology Institute:
Tumor-stopping Antibody
Biotechnological human antibody drug agent for use in the treatment of cancer and eye diseases
Product Properties:
Pages
